Navigating Challenges: Extracorporeal Membrane Oxygenation for Respiratory Syncytial Virus Acute Respiratory Distress Syndrome in a Post-hematopoietic Stem Cell Transplantation Infant

Respiratory syncytial virus (RSV) infection significantly increases morbidity and mortality in immunocompromised patients, especially those undergoing hematopoietic stem cell transplantation (HSCT).Recent advancements in ECMO and HSCT management have improved survival in this population.We present a complex case of a 10-month-old post-HSCT infant who required venoarterial (VA) ECMO support for severe RSV-associated ARDS, highlighting the challenges and strategies in managing immunocompromised children on ECMO.